Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report

Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report

Background: Clozapine is among the most effective antipsychotics used for treatment resistant schizophrenia. Adverse reactions to clozapine include neutropenia. In March 2020, at the start of the Coronavirus −19 pandemic, clinicians raised concerns regarding continuation of antipsychotic treatment,...

Full description

Bibliographic Details
Main Authors: Stefania Bonaccorso, Angelo Ricciardi, Sophie Ouabbou, Christos Theleritis, Arabella Ross-Michaelides, Antonio Metastasio, Neil Stewart, Marwa Mohammed, Fabrizio Schifano
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:Brain, Behavior, & Immunity - Health
Subjects:
Clozapine
Coronavirus
COVID-19
SARS-CoV-2
Psychosis
Schizophrenia
Online Access:http://www.sciencedirect.com/science/article/pii/S2666354621000156

Similar Items

Similar Items